Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)
CNY 3.81
(0.26%)
CNY 3.81
(0.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.85 Million CNY | -86.95% |
| 2022 | 21.87 Million CNY | -93.01% |
| 2021 | 312.71 Million CNY | -24.58% |
| 2020 | 414.61 Million CNY | 667.81% |
| 2019 | 54 Million CNY | -86.76% |
| 2018 | 407.9 Million CNY | -8.65% |
| 2017 | 446.54 Million CNY | 39.96% |
| 2016 | 319.06 Million CNY | -50.89% |
| 2015 | 649.68 Million CNY | 101.14% |
| 2014 | 323 Million CNY | -3.48% |
| 2013 | 334.65 Million CNY | 52.11% |
| 2012 | 220 Million CNY | 71.88% |
| 2011 | 128 Million CNY | -40.47% |
| 2010 | 215 Million CNY | 34.52% |
| 2009 | 159.82 Million CNY | 73.44% |
| 2008 | 92.15 Million CNY | -22.85% |
| 2007 | 119.45 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.31 Million CNY | -18.93% |
| 2024 Q2 | 2.22 Million CNY | -3.74% |
| 2024 Q3 | 30.16 Million CNY | -56.46% |
| 2023 FY | 2.85 Million CNY | -86.95% |
| 2023 Q1 | 22.09 Million CNY | 1.0% |
| 2023 Q4 | 2.85 Million CNY | 4.81% |
| 2023 Q2 | 2.68 Million CNY | -87.84% |
| 2023 Q3 | 2.72 Million CNY | 1.35% |
| 2022 Q3 | 74.44 Million CNY | -76.85% |
| 2022 Q2 | 321.62 Million CNY | 3.15% |
| 2022 Q1 | 311.81 Million CNY | -0.29% |
| 2022 FY | 21.87 Million CNY | -93.01% |
| 2022 Q4 | 21.87 Million CNY | -70.62% |
| 2021 Q1 | 265.5 Million CNY | -35.96% |
| 2021 Q3 | 450.47 Million CNY | 10.98% |
| 2021 FY | 312.71 Million CNY | -24.58% |
| 2021 Q4 | 312.71 Million CNY | -30.58% |
| 2021 Q2 | 405.91 Million CNY | 52.89% |
| 2020 Q3 | 447 Million CNY | 27.71% |
| 2020 Q1 | 281.5 Million CNY | 421.3% |
| 2020 FY | 414.61 Million CNY | 667.81% |
| 2020 Q2 | 350 Million CNY | 24.33% |
| 2020 Q4 | 414.61 Million CNY | -7.24% |
| 2019 Q1 | 402.5 Million CNY | -1.33% |
| 2019 FY | 54 Million CNY | -86.76% |
| 2019 Q4 | 54 Million CNY | -52.42% |
| 2019 Q3 | 113.5 Million CNY | -63.8% |
| 2019 Q2 | 313.5 Million CNY | -22.11% |
| 2018 Q1 | 407.01 Million CNY | -8.85% |
| 2018 Q3 | 436.95 Million CNY | -1.44% |
| 2018 FY | 407.9 Million CNY | -8.65% |
| 2018 Q2 | 443.31 Million CNY | 8.92% |
| 2018 Q4 | 407.9 Million CNY | -6.65% |
| 2017 Q3 | 367.91 Million CNY | -15.25% |
| 2017 Q2 | 434.11 Million CNY | 30.97% |
| 2017 Q1 | 331.45 Million CNY | 3.88% |
| 2017 Q4 | 446.54 Million CNY | 21.37% |
| 2017 FY | 446.54 Million CNY | 39.96% |
| 2016 FY | 319.06 Million CNY | -50.89% |
| 2016 Q3 | 386.51 Million CNY | -39.01% |
| 2016 Q4 | 319.06 Million CNY | -17.45% |
| 2016 Q1 | 727.23 Million CNY | 11.94% |
| 2016 Q2 | 633.76 Million CNY | -12.85% |
| 2015 Q2 | 415 Million CNY | 33.87% |
| 2015 Q4 | 649.68 Million CNY | 60.42% |
| 2015 FY | 649.68 Million CNY | 101.14% |
| 2015 Q1 | 310 Million CNY | -4.02% |
| 2015 Q3 | 405 Million CNY | -2.41% |
| 2014 Q1 | 322.65 Million CNY | -3.59% |
| 2014 FY | 323 Million CNY | -3.48% |
| 2014 Q4 | 323 Million CNY | -23.1% |
| 2014 Q3 | 420 Million CNY | -5.12% |
| 2014 Q2 | 442.65 Million CNY | 37.19% |
| 2013 Q2 | 350 Million CNY | 9.38% |
| 2013 Q4 | 334.65 Million CNY | -5.64% |
| 2013 Q3 | 354.65 Million CNY | 1.33% |
| 2013 Q1 | 320 Million CNY | 45.45% |
| 2013 FY | 334.65 Million CNY | 52.11% |
| 2012 Q3 | 255 Million CNY | 25.62% |
| 2012 FY | 220 Million CNY | 71.88% |
| 2012 Q1 | 220 Million CNY | 71.88% |
| 2012 Q2 | 203 Million CNY | -7.73% |
| 2012 Q4 | 220 Million CNY | -13.73% |
| 2011 Q3 | 178 Million CNY | 143.84% |
| 2011 FY | 128 Million CNY | -40.47% |
| 2011 Q1 | 53 Million CNY | -75.35% |
| 2011 Q2 | 73 Million CNY | 37.74% |
| 2011 Q4 | 128 Million CNY | -28.09% |
| 2010 Q2 | 195.32 Million CNY | 0.0% |
| 2010 Q4 | 215 Million CNY | -4.58% |
| 2010 FY | 215 Million CNY | 34.52% |
| 2010 Q3 | 225.32 Million CNY | 15.36% |
| 2009 Q4 | 159.82 Million CNY | 0.0% |
| 2009 FY | 159.82 Million CNY | 73.44% |
| 2008 FY | 92.15 Million CNY | -22.85% |
| 2007 FY | 119.45 Million CNY | 0.0% |